AXSM vs CLOV · rev $385.7M vs rev $1.37B
Axsome Therapeutics Inc (AXSM) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AXSM revenue for 2024-12-31 was $385.7M. Net income was -$287.2M. Revenue was up 42.5% from 2023-12-31 to 2024-12-31. AXSM currently screens at market cap $11.96B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AXSM currently screens at market cap $11.96B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AXSM and CLOV stock pages for the full models.
Not investment advice.